Search for: "MERRELL v. U.S." Results 201 - 220 of 354
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jun 2013, 9:42 pm
More pithily, Lord Hoffmann noted in Merrell Dow [1996] RPR 76 noted that “An invention is a piece of information. [read post]
17 Nov 2015, 5:00 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), was a Bendectin case − but widespread, teratogenicity allegations forced off the market what was then the only drug FDA approved for the treatment of morning sickness. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
31 Mar 2016, 8:09 am by Jetta Sandin and Jay Levine
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
18 May 2011, 4:08 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 [1993]) to determine whether expert scientific testimony is admissible. [read post]
3 Feb 2012, 12:12 am by Eugene Volokh
Merrell Dow Pharms., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993) ( “Daubert hearing”) was necessary to test the admissibility of Professor Barkun’s testimony. [read post]
10 Sep 2007, 3:47 pm
Merrell Dow Pharm., 509 U.S. 579 (1993)     Popper, Conjectures and Refutations (5th ed. 1989)     Neil Feigenson, Brain Imaging and Courtroom Evidence (2006). [read post]